CRITICAL THERAPEUTICS,INC.
Critical Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative products for respiratory and inflammatory diseases.
CRITICAL THERAPEUTICS,INC.
Industry:
Biopharma Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics
Founded:
2000-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.criticaltherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(781) 402-5700
Total Funding:
66 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Current Advisors List
Investors List
Advanced Technology Ventures
Advanced Technology Ventures investment in Series B - Critical Therapeutics,Inc.
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Critical Therapeutics,Inc.
MPM Capital
MPM Capital investment in Series B - Critical Therapeutics,Inc.
HealthCare Ventures
HealthCare Ventures investment in Series B - Critical Therapeutics,Inc.
MedImmune Ventures
MedImmune Ventures investment in Series B - Critical Therapeutics,Inc.
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series B - Critical Therapeutics,Inc.
MPM Capital
MPM Capital investment in Series A - Critical Therapeutics,Inc.
HealthCare Ventures
HealthCare Ventures investment in Series A - Critical Therapeutics,Inc.
Official Site Inspections
http://www.criticaltherapeutics.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Critical Therapeutics,Inc."
Critical Therapeutics Inc., Frank E. Thomas, fthomas ...
Company Name Critical Therapeutics Inc. Ticker Symbol CRTX Address 60 Westview St. Lexington, MA 02421 United States Email [email protected] Phone 1-781-402-5700 …See details»
Critical Therapeutics,Inc. - Crunchbase Company Profile …
Critical Therapeutics, Inc. is a privately held biopharmaceutical company focused on critical care medicine.See details»
Critical Therapeutics Company Profile | Management and
Find contact information for Critical Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and Critical Therapeutics's email format.See details»
Organization | Critical Therapeutics
Critical Therapeutics Report issue For profit Phase 2 Phase 4 Founded: Lexington MA United States (2000) Status: Acquired by Cornerstone Therapeutics (2008) → now Chiesi (2014)See details»
Critical Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
May 7, 2025 Explore Critical Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 7 news, and 3 literature, Drug:Ethyl Pyruvate ...See details»
Critical Therapeutics,Inc. - Company Profile & Staff Directory
Critical Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative products for respiratory and inflammatory diseases.See details»
www.criticaltherapeutics.com
Www.criticaltherapeutics.comSee details»
Critical Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Critical Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Cornerstone BioPharma Announces Completion of Merger with …
Nov 3, 2008 Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics Combined Company Renamed Cornerstone Therapeutics Inc. and to Continue …See details»
Critical Therapeutics, Inc.:Company Profile & Technical Research ...
Critical Therapeutics, Inc. is a company that provides Clinical trial, Pharmacy and Therapeutics and more. Critical Therapeutics, Inc. is headquartered in United States Massachusetts.See details»
Critical Therapeutics,Inc. - Crunchbase
Critical Therapeutics, Inc., Akashi Therapeutics, Adgero Biopharmaceuticals, Inc., Talon Therapeutics, iviGene, and Endece are all involved in the biopharmaceutical industry. Akashi …See details»
Critical Therapeutics,Inc. - Financial Details - Crunchbase
Critical Therapeutics, Inc. is a privately held biopharmaceutical company focused on critical care medicine.See details»
Critical Therapeutics, Inc. Signs Definitive Agreement to ... - BioSpace
May 2, 2008 LEXINGTON, Mass. and CARY, N.C.-- (BUSINESS WIRE)--Critical Therapeutics, Inc. (NASDAQ: CRTX) and Cornerstone BioPharma Holdings, Inc., a privately-held company, …See details»
exv99w1 - SEC.gov
The merger between Critical Therapeutics and Cornerstone creates a specialty pharmaceutical company focused on respiratory diseases, said Trevor Phillips, Ph.D., president and chief …See details»
Frank Thomas Research by SuperAGI
Professional Overview Frank Thomas is the CEO of Critical Therapeutics, a leading biopharmaceutical company focused on developing innovative treatments for critical medical …See details»
Critical Therapeutics gets US okay on asthma drug | Reuters
May 31, 2007 Critical Therapeutics Inc. <CRTX.O> said its twice-daily extended-release asthma drug got U.S. marketing approval, and the company's shares rose more than 50 percent in pre …See details»
Critical Therapeutics,Inc. - News & Analysis - Crunchbase
Critical Therapeutics, Inc. is a privately held biopharmaceutical company focused on critical care medicine.See details»
Critical Therapeutics Signs Definitive Agreement to Merge with ...
May 2, 2008 The merger agreement provides for Critical Therapeutics to issue in the merger to Cornerstone stockholders, and assume Cornerstone options and warrants that will represent, …See details»
History - CHIESI USA
Today Chiesi is still very much a family-led organization that embraces its entrepreneurial roots. The company continually strives to not only develop innovative solutions for its current …See details»
U.S. mRNA Therapeutics Contract Development & Manufacturing ...
Aug 7, 2025 Key U.S. mRNA Therapeutics Contract Development & Manufacturing Organization Company Insights The key players operating across the industry are implementing several …See details»